Israel Englander Harvard Bioscience Inc Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Millennium Management LLC holds 148,422 shares of HBIO stock, worth $418,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148,422
Previous 18,969
682.45%
Holding current value
$418,550
Previous $80,000
428.75%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding HBIO
# of Institutions
107Shares Held
32.1MCall Options Held
1.2KPut Options Held
1.2K-
Black Rock Inc. New York, NY2.84MShares$8.02 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$7.82 Million0.49% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.56MShares$7.21 Million0.9% of portfolio
-
Amh Equity LTD2.39MShares$6.74 Million8.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$5.97 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $117M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...